Relapse versus reinfection: Surveillance of clostridium difficile infection

Clinical Infectious Diseases

Volumn 53, Issue 10, 2011, Pages 1003-1006

  Kamboj, Mini ^a,b   Khosa, Perminder ^b   Kaltsas, Anna ^a   Babady, N Esther ^c   Son, Crystal ^b   Sepkowitz, Kent A ^a,b  

^a Infectious Disease Service   (United States)

^b Department of Medicine ^*  (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DEHYDROGENASE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE COURSE; DISEASE SURVEILLANCE; ENZYME IMMUNOASSAY; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT INFECTION; RELAPSE; RIBOTYPING;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HUMANS; INCIDENCE; MOLECULAR TYPING; PREVALENCE; RECURRENCE; SEASONS; TIME FACTORS;

EID: 80054730409     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir643     Document Type: Article

References (13)

1. Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: An underappreciated and increasing cause of death and complications. Ann Surg 2002; 235:363-72. (Pubitemid 34183887)
2. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin genevariant strain of Clostridium difficile. N Engl J Med 2005; 353:2433-41. (Pubitemid 41770164)
3. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005; 173:1037-42. PMCID: 1266326.
4. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28:140-5. (Pubitemid 46374153)
5. Bidet P, Barbut F, Lalande V, Burghoffer B, Petit JC. Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett 1999; 175:261-6. (Pubitemid 29352246)
6. Kuijper EJ, Barbut F, Brazier JS, et al. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 2008; 13:18942.
7. Alonso R, Gros S, Pelaez T, Garcia-de-Viedma D, Rodriguez-Creixems M, Bouza E. Molecular analysis of relapse vs re-infection in HIVpositive patients suffering from recurrent Clostridium difficile associated diarrhoea. J Hosp Infect 2001; 48:86-92. (Pubitemid 32700706)
8. Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit JC. Epidemiology of recurrences or reinfections of Clostridium difficileassociated diarrhea. J Clin Microbiol 2000; 38:2386-8. PMCID: 86814.
9. Johnson S, Adelmann A, Clabots CR, Peterson LR, Gerding DN. Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism. J Infect Dis 1989; 159:340-3. (Pubitemid 19049377)
10. O'Neill GL, Beaman MH, Riley TV. Relapse versus reinfection with Clostridium difficile. Epidemiol Infect 1991; 107:627-35. PMCID: 2272080.
11. Tang-Feldman Y, Mayo S, Silva Jr. J Jr., Cohen SH. Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea. J Clin Microbiol 2003; 41:3413-4. PMCID: 165369. (Pubitemid 36842364)
12. Wilcox MH, Fawley WN, Settle CD, Davidson A. Recurrence of symptoms in Clostridium difficile infection-relapse or reinfection? J Hosp Infect 1998; 38:93-100. (Pubitemid 28143351)
13. Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol 2010; 31:21-7.